Abstract
It is well known that the majority of synthetic materials currently in use, by virtue of being foreign bodies, tend to sustain an inflammatory response at the surgical site. This is largely attributed to their inadequate biological inertness or suboptimal structural properties, which may further exacerbate tissue reactivity.
The implantation of mesh endoprostheses has been linked to a heightened risk of postoperative purulent-inflammatory wound complications, posing a significant challenge in surgical practice. The prevention and management of both localized and systemic postoperative complications remain complex issues, with reported incidence rates reaching as high as 35%.